1. Home
  2. BCDA vs WKSP Comparison

BCDA vs WKSP Comparison

Compare BCDA & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCDA

BioCardia Inc.

N/A

Current Price

$1.19

Market Cap

12.4M

Sector

Health Care

ML Signal

N/A

Logo Worksport Ltd.

WKSP

Worksport Ltd.

HOLD

Current Price

$1.35

Market Cap

12.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCDA
WKSP
Founded
N/A
2003
Country
United States
United States
Employees
17
81
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.4M
12.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BCDA
WKSP
Price
$1.19
$1.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$25.00
$9.25
AVG Volume (30 Days)
59.4K
434.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$94.77
Revenue Next Year
N/A
$127.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.36
52 Week High
$3.20
$4.90

Technical Indicators

Market Signals
Indicator
BCDA
WKSP
Relative Strength Index (RSI) 47.92 38.57
Support Level $1.13 $1.00
Resistance Level $1.33 $1.63
Average True Range (ATR) 0.09 0.18
MACD 0.01 0.01
Stochastic Oscillator 38.45 55.56

Price Performance

Historical Comparison
BCDA
WKSP

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About WKSP Worksport Ltd.

Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.

Share on Social Networks: